Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-05 07:00:45 - browse：76392

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： An interview with Robert F. Kennedy Jr. on vaccines

WSS

NIH confirmation hearing shows politicization of research

New definition of a human embryo proposed amid rapid advances

New definition of a human embryo proposed amid rapid advances

FDA warns J&J's Abiomed: We will regulate your software

STAT Summit: How a Chicago ER doctor tackles gun violence

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

leisure time

Wikipedia

hotspot

Psychedelics group wrestles with new pharma identity

Studies point to risks of excluding people with obesity from drug trials

Bright Health sells Medicare Advantage business to Molina

The explosion of genetic testing requires a new approach

Medicare proposal to cover medical devices draws a mixed reaction

Eye stem cell transplant could help restore vision in injured people

In Memoriam: Notable people who died in 2023

Hilary may become 1st tropical storm to make landfall in California in 84 years

Sports medicine is finally prioritizing gender equality

Hilary may become 1st tropical storm to make landfall in California in 84 years

focus

Living with Hashimoto's and celiac disease, and med school, too

Pharmacists can make shortage drugs, but at what cost?

Will Ozempic

Congress must give Medicare recipients genetic counseling access

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Patient advocates sound warning on FDA proposal on salt intake

Wikipedia

explore

hotspot

hotspot